Abstract
One of the parenchymal organs that can be affected in patients with Sjögren’s syndrome (SS) is the kidney [1]. Kidneys in primary SS (pSS) can be a target of the immune system either by activated lymphocytes that infiltrate the renal interstitium resulting in interstitial nephritis (IN) or by an immune complex mediated process appearing as glomerulonephritis (GN). Furthermore, epidemiologic and immunologic data suggest an association between SS and painful bladder syndrome/interstitial cystitis (PBS/IC), a chronic pelvic pain syndrome that produces lower urinary symptoms such as discomfort related to bladder, nocturia, frequency, and urge to void [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tzioufas G, Mitsias D, Moutsopoulos H. Sjogren’s syndrome. In: Hochberg M, Smolen J, Weinblatt M, Weisman M, editors. Rheumatology. 4th ed. Mosby: Elsevier; 2008. p. 1341.
Kahn M, Merritt AD, Wohl MJ, et al. Renal concentrating defect in Sjogren’s syndrome. Ann Intern Med. 1962;56:883–95.
Shearn MA, Tu WH. Nephrogenic diabetic insipidus and other defects of renal tubular function in Sjoergren’s syndrome. Am J Med. 1965;39:312–8.
Bloch KJ, Buchanan WW, Wohl MJ, et al. Sjogren’s syndrome. A clinical, pathological, and serological study of sixty-two cases. Medicine (Baltimore). 1965;44:187–231.
Shearn MA, Tu WH. Latent renal tubular acidosis in Sjogren’s syndrome. Ann Rheum Dis. 1968;27:27–32.
Tu WH, Shearn MA, Lee JC, et al. Interstitial nephritis in Sjogren’s syndrome. Ann Intern Med. 1968;69:1163–70.
Talal N, Zisman E, Schur PH. Renal tubular acidosis, glomerulonephritis and immunologic factors in Sjogren’s syndrome. Arthritis Rheum. 1968;11:774–86.
Shioji R, Furuyama T, Onodera S, et al. Sjogren’s syndrome and renal tubular acidosis. Am J Med. 1970;48:456–63.
Eriksson P, Denneberg T, Enestrom S, et al. Urolithiasis and distal renal tubular acidosis preceding primary Sjogren’s syndrome: a retrospective study 5–53 years after the presentation of urolithiasis. J Intern Med. 1996;239:483–8.
Pertovaara M, Korpela M, Pasternack A. Factors predictive of renal involvement in patients with primary Sjogren’s syndrome. Clin Nephrol. 2001;56:10–8.
Aasarod K, Haga HJ, Berg KJ, et al. Renal involvement in primary Sjogren’s syndrome. QJM. 2000;93:297–304.
Bossini N, Savoldi S, Franceschini F, et al. Clinical and morphological features of kidney involvement in primary Sjogren’s syndrome. Nephrol Dial Transplant. 2001;16:2328–36.
Pertovaara M, Korpela M, Kouri T, et al. The occurrence of renal involvement in primary Sjogren’s syndrome: a study of 78 patients. Rheumatology (Oxford). 1999;38:1113–20.
Pokorny G, Sonkodi S, Ivanyi B, et al. Renal involvement in patients with primary Sjogren’s syndrome. Scand J Rheumatol. 1989;18:231–4.
Viergever PP, Swaak TJ. Renal tubular dysfunction in primary Sjogren’s syndrome: clinical studies in 27 patients. Clin Rheumatol. 1991;10:23–7.
Vitali C, Tavoni A, Sciuto M, et al. Renal involvement in primary Sjogren’s syndrome: a retrospective-prospective study. Scand J Rheumatol. 1991;20:132–6.
Siamopoulos KC, Mavridis AK, Elisaf M, et al. Kidney involvement in primary Sjogren’s syndrome. Scand J Rheumatol Suppl. 1986;61:156–60.
Moutsopoulos HM, Cledes J, Skopouli FN, et al. Nephrocalcinosis in Sjogren’s syndrome: a late sequela of renal tubular acidosis. J Intern Med. 1991;230:187–91.
Aygen B, Dursun FE, Dogukan A, et al. Hypokalemic quadriparesis associated with renal tubular acidosis in a patient with Sjogren’s syndrome. Clin Nephrol. 2008;69:306–9.
Dowd JE, Lipsky PE. Sjogren’s syndrome presenting as hypokalemic periodic paralysis. Arthritis Rheum. 1993;36:1735–8.
Soy M, Pamuk ON, Gerenli M, et al. A primary Sjogren’s syndrome patient with distal renal tubular acidosis, who presented with symptoms of hypokalemic periodic paralysis: report of a case study and review of the literature. Rheumatol Int. 2005;26:86–9.
Zimhony O, Sthoeger Z, Ben David D, et al. Sjogren’s syndrome presenting as hypokalemic paralysis due to distal renal tubular acidosis. J Rheumatol. 1995;22:2366–8.
Ren H, Wang WM, Chen XN, et al. Renal involvement and follow-up of 130 patients with primary Sjogren’s syndrome. J Rheumatol. 2008;35:278–84.
Kobayashi T, Muto S, Nemoto J, et al. Fanconi’s syndrome and distal (type 1) renal tubular acidosis in a patient with primary Sjogren’s syndrome with monoclonal gammopathy of undetermined significance. Clin Nephrol. 2006;65:427–32.
Yang Y, Kuang Y, Montes De Oca R. Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9. Blood. 2001;98:3435–40.
Goules A, Masouridi S, Tzioufas AG, et al. Clinically significant and biopsy-documented renal involvement in primary Sjogren syndrome. Medicine (Baltimore). 2000;79:241–9.
Matsumura R, Kondo Y, Sugiyama T, et al. Immunohistochemical identification of infiltrating mononuclear cells in tubulointerstitial nephritis associated with Sjogren’s syndrome. Clin Nephrol. 1988;30:335–40.
Rosenberg ME, Schendel PB, McCurdy FA, et al. Characterization of immune cells in kidneys from patients with Sjogren’s syndrome. Am J Kidney Dis. 1988;11:20–2.
Murata H, Kita Y, Sakamoto A, et al. Limited TCR repertoire of infiltrating T cells in the kidneys of Sjogren’s syndrome patients with interstitial nephritis. J Immunol. 1995;155:4084–9.
Matsumura R, Umemiya K, Nakazawa T, et al. Expression of cell adhesion molecules in tubulointerstitial nephritis associated with Sjogren’s syndrome. Clin Nephrol. 1998;49:74–81.
Matsumura R, Umemiya K, Goto T, et al. Glandular and extraglandular expression of costimulatory molecules in patients with Sjogren’s syndrome. Ann Rheum Dis. 2001;60:473–82.
Matsumura R, Umemiya K, Kagami M, et al. Glandular and extraglandular expression of the Fas-Fas ligand and apoptosis in patients with Sjogren’s syndrome. Clin Exp Rheumatol. 2001;16:561–8.
Nishimori I, Bratanova T, Toshkov I, et al. Induction of experimental autoimmune sialoadenitis by immunization of PL/J mice with carbonic anhydrase II. J Immunol. 1995;154:4865–73.
Inagaki Y, Jinno-Yoshida Y, Hamasaki Y, et al. A novel autoantibody reactive with carbonic anhydrase in sera from patients with systemic lupus erythematosus and Sjogren’s syndrome. J Dermatol Sci. 1991;2:147–54.
Itoh Y, Reichlin M. Antibodies to carbonic anhydrase in systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum. 1992;35:73–82.
Kino-Ohsaki J, Nishimori I, Morita M, et al. Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjogren’s syndrome. Gastroenterology. 1996;110:1579–86.
Takemoto F, Hoshino J, Sawa N, et al. Autoantibodies against carbonic anhydrase II are increased in renal tubular acidosis associated with Sjogren syndrome. Am J Med. 2005;118:181–4.
Takemoto F, Katori H, Sawa N, et al. Induction of anti-carbonic-anhydrase-II antibody causes renal tubular acidosis in a mouse model of Sjogren’s syndrome. Nephron Physiol. 2007;106:p63–8.
Rodriguez Soriano J. Renal tubular acidosis: the clinical entity. J Am Soc Nephrol. 2002;13:2160–70.
Maldonado JE, Velosa JA, Kyle RA, et al. Fanconi syndrome in adults. A manifestation of a latent form of myeloma. Am J Med. 1975;58:354–64.
Donckerwolcke RA, van Stekelenburg GJ, Tiddens HA. Therapy of bicarbonate-losing renal tubular acidosis. Arch Dis Child. 1970;45:774–9.
Maripuri S, Grande JP, Osborn TG, et al. Renal involvement in primary Sjogren’s syndrome: a clinicopathologic study. Clin J Am Soc Nephrol. 2009;4:1423–31.
Meltzer M, Franklin EC, Elias K, et al. Cryoglobulinemia – a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med. 1966;40:837–56.
Brouet JC, Clauvel JP, Danon F, et al. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med. 1974;57:775–88.
Moutsopoulos HM, Balow JE, Lawley TJ, et al. Immune complex glomerulonephritis in sicca syndrome. Am J Med. 1978;64:955–60.
Sato K, Miyasaka N, Nishioka K, et al. Primary Sjogren’s syndrome associated with systemic necrotizing vasculitis: a fatal case. Arthritis Rheum. 1987;30:717–8.
Tsokos M, Lazarou SA, Moutsopoulos HM. Vasculitis in primary Sjogren’s syndrome. Histologic classification and clinical presentation. Am J Clin Pathol. 1987;88:26–31.
Ferri C, Zignego AL, Pileri SA. Cryoglobulins. J Clin Pathol. 2002;55:4–13.
Dimitrakopoulos AN, Kordossis T, Hatzakis A, et al. Mixed cryoglobulinemia in HIV-1 infection: the role of HIV-1. Ann Intern Med. 1999;130:226–30.
Vitali C, Sciuto M, Neri R, et al. Anti-hepatitis C virus antibodies in primary Sjogren’s syndrome: false positive results are related to hyper-gamma-globulinemia. Clin Exp Rheumatol. 1992;10:103–4.
Abrams P, Baranowski A, Berger RE, et al. A new classification is needed for pelvic pain syndromes – are existing terminologies of spurious diagnostic authority bad for patients? J Urol. 2006;175:1989–90.
Fall M, Baranowski AP, Fowler CJ, et al. EAU guidelines on chronic pelvic pain. Eur Urol. 2004;46:681–9.
Janicki TI. Chronic pelvic pain as a form of complex regional pain syndrome. Clin Obstet Gynecol. 2003;46:797–803.
van de Merwe JP, Nordling J, Bouchelouche P, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53:60–7.
Hanash KA, Pool TL. Interstitial cystitis in men. J Urol. 1969;102:427–8.
Messing EM, Stamey TA. Interstitial cystitis: early diagnosis, pathology, and treatment. Urology. 1978;12:381–92.
Van de Merwe J, Kamerling R, Arendsen E, et al. Sjogren’s syndrome in patients with interstitial cystitis. J Rheumatol. 1993;20:962–6.
Ustinova EE, Fraser MO, Pezzone MA. Cross-talk and sensitization of bladder afferent nerves. Neurourol Urodyn. 2010;29:77–81.
Rodriguez MA, Afari N, Buchwald DS. Evidence for overlap between urological and nonurological unexplained clinical conditions. J Urol. 2009;182:2123–31.
Butrick CW, Sanford D, Hou Q, et al. Chronic pelvic pain syndromes: clinical, urodynamic, and urothelial observations. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20:1047–53.
Sastry DN, Hunter KM, Whitmore KE. Urodynamic testing and interstitial cystitis/painful bladder syndrome. Int Urogynecol J Pelvic Floor Dysfunct. 2010;21:157–61.
Dasgupta J, Tincello DG. Interstitial cystitis/bladder pain syndrome: an update. Maturitas. 2009;64:212–7.
Ochs RL, Stein Jr TW, Peebles CL, et al. Autoantibodies in interstitial cystitis. J Urol. 1994;151:587–92.
Helin H, Mattila J, Rantala I, et al. In vivo binding of immunoglobulin and complement to elastic structures in urinary bladder vascular walls in interstitial cystitis: demonstration by immunoelectron microscopy. Clin Immunol Immunopathol. 1987;43:88–96.
Christmas TJ, Bottazzo GF. Abnormal urothelial HLA-DR expression in interstitial cystitis. Clin Exp Immunol. 1992;87:450–4.
Christmas TJ. Lymphocyte sub-populations in the bladder wall in normal bladder, bacterial cystitis and interstitial cystitis. Br J Urol. 1994;73:508–15.
Haarala M, Alanen A, Hietarinta M, et al. Lower urinary tract symptoms in patients with Sjogren’s syndrome and systemic lupus erythematosus. Int Urogynecol J Pelvic Floor Dysfunct. 2000;11:84–6.
Leppilahti M, Tammela TL, Huhtala H, et al. Interstitial cystitis-like urinary symptoms among patients with Sjogren’s syndrome: a population-based study in Finland. Am J Med. 2003;115:62–5.
van de Merwe JP. Interstitial cystitis and systemic autoimmune diseases. Nat Clin Pract Urol. 2007;4:484–91.
Fall M, Oberpenning F, Peeker R. Treatment of bladder pain syndrome/interstitial cystitis 2008: can we make evidence-based decisions? Eur Urol. 2008;54:65–75.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag London Limited
About this chapter
Cite this chapter
Goules, A.V., Moutsopoulos, H.M. (2011). Nephro-Urological Involvement. In: Ramos-Casals, M., Stone, J., Moutsopoulos, H. (eds) Sjögren’s Syndrome. Springer, London. https://doi.org/10.1007/978-0-85729-947-5_19
Download citation
DOI: https://doi.org/10.1007/978-0-85729-947-5_19
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-946-8
Online ISBN: 978-0-85729-947-5
eBook Packages: MedicineMedicine (R0)